Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
- A8487 Nocodazole1 CitationTarget: Microtubules/TubulinsSummary: Tubulin production inhibitor,anti-neoplastic agent
- A8544 Wortmannin5 CitationSummary: PI3K inhibitor,selective and irreversible
- A8627 Bafilomycin A15 CitationSummary: V-ATPase inhibitor,selective and reversible
- A8628 Chloroquine diphosphate1 CitationTarget: AutophagySummary: Antimalarial drug,TLR7 TLR9 inhibitor
- A8629 DBeQTarget: P97 ATPaseSummary: P97 ATPase inhibitor
- A8630 XanthohumolSummary: VCP inhibitor
- A8631 FK 866 hydrochlorideTarget: NMPRTaseSummary: NMPRTase inhibitor
- A8632 (±)-Bay K 8644Summary: L-type Ca2+-channel activator
- A8633 Concanamycin A1 CitationTarget: Vacuolar-type ATPaseSummary: V-type (vacuolar) H+-ATPase inhibitor
- A8661 MNSSummary: Inhibitor of Src/Syk tyrosine kinases